Latest chemotherapy Stories
ORLANDO, Fla., April 27, 2015 /PRNewswire/ -- Nurses from the Cancer Treatment Centers of America® (CTCA) revealed new research on patient-centered care, pain management and bedside reporting at the
STAR Study Results Presented at the American Surgical Association Annual Meeting SAN DIEGO, April 24, 2015 /PRNewswire/ -- University of Louisville announced today results from the
EWING, N.J., April 22, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
CAMBRIDGE, England, April 21, 2015 /PRNewswire/ -- Acacia Pharma Ltd ("Acacia Pharma" or "the Company"), the supportive care company developing products for US and international
-- Animal model highly representative of late-stage ovarian cancer in women PHILADEPHIA, April 20, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT;
-- TRXE-009 distinguished by ability to kill chemo-resistant adult and paediatric brain cancer cells SYDNEY, April 17, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today
Don't let nausea stop you from doing what you want.
QUÉBEC CITY, April 16, 2015 /PRNewswire/ - Aeterna Zentaris Inc.
After almost five months of chemotherapy and radiation, the news was not good for Ken Cooper.
LUGANO, Switzerland and WOODCLIFF LAKE, N.J., April 15, 2015 /PRNewswire/ -- Helsinn Group and Eisai Inc.
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
- A serpent whose bite was fabled to produce intense thirst.